Robert J. Behrens

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

Joon H. Uhm, Karla V. Ballman, Wenting Wu et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 181 citations · Full text

Neuro-oncology, Phase Ii Evaluation, Malignant Disease +11

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers

Antoun Toubaji, M. S. Achtar, Maurizio Provenzano et al. · Cancer Immunology Immunotherapy · 2008 · 120 citations · Full text

Vaccination, Colorectal Cancers, Immunology +9

A phase II trial of nab‐paclitaxel (ABI‐007) and carboplatin in patients with unresectable stage IV melanoma

Lisa A. Kottschade, Vera J. Suman, Thomas Amatruda et al. · Cancer · 2010 · 96 citations · Full text

North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study

Alexis D. Leal, Rui Qin, Pamela J. Atherton et al. · Cancer · 2014 · 84 citations · Full text

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

Kalliopi P. Siziopikou, Stewart Anderson, Melody Cobleigh et al. · Breast Cancer Research and Treatment · 2013 · 74 citations

Tumor Biology, Breast Oncology, Centralized Her2 Testing +10